The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

The pledge comes as the United States plans to leave the international organization, The Washington Post reported.

Investigators present 48 month follow-up data from a phase 2b trial on padeliporfin vascular-targeted photodynamic therapy for intermediate-risk prostate cancer.

Investigators aimed to identify an optimal PSA cut-off to define PSA persistence after prostate cancer surgery using new ultrasensitive assay methods.

(HealthDay News) — Metabolic dysfunction-associated steatotic liver disease (MASLD) in pregnant women is a risk factor for preterm birth, according to a study published online May 9 in ...

The FDA has accepted for Priority Review the BLA for sibeprenlimab for the treatment of immunoglobulin A nephropathy in adults.

The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported.

Simple stratification based on hospitalization history and diuretic use can predict outcomes for heart failure patients.

GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.